| Similar Articles |
|---|
 |
Bio-IT World
May 7, 2002
Dave Brambert |
Accelerating the Fight Against AIDS The Waterford Project's collaborative software and high-speed networking are bringing researchers together in a search for an HIV/AIDS vaccine.   |
Pharmaceutical Executive
June 1, 2005
Seth Berkley |
Backpage: Partnering for Vaccine Victories Public-private partnerships can help engage industry in AIDS vaccine research. Pharma and biotechnology companies should respond with the expertise that only they can offer. |
BusinessWeek
September 2, 2010
Simeon Bennett |
David Margolis' Fight to End AIDS The North Carolina professor is relying on Zolinza, a rarely used Merck cancer drug, to stamp out AIDS. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
Fast Company
August 8, 2011
Kate Rockwood |
AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive. |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
BusinessWeek
August 5, 2010
Bennett & Randall |
AIDS Drugs Flow to the Third World Drugmakers, once blasted for their practices, are slashing prices and licensing AIDS drugs for free to nonprofits or local manufacturers in developing countries. |
Salon.com
July 28, 2000
Kate Scanell |
Contributing to genocide By giving HIV deniers a global platform, South African President Mbeki has put countless lives at risk. |
Salon.com
June 25, 2001
Daryl Lindsey |
AIDS activists change their act On the eve of a United Nations conference, the once-militant ACT-UP revises its tactics and focus... |
Chemistry World
July 6, 2015
Rebecca Trager |
Scientist imprisoned over fraudulent HIV vaccine research An ex-Iowa State University scientist has been sentenced to four-and-a-half years in prison for faking Aids vaccine research funded by the US National Institutes of Health |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
Pharmaceutical Executive
October 1, 2011
William Looney |
The Crisis Manager Peter Piot continues his dual role as Director of the London School of Hygiene and Tropical Medicine, where he promotes systemwide innovations in public health while applying his deep knowledge of the HIV environment to raise the visibility of non-communicable diseases on the global policy agenda. |
Chemistry World
September 3, 2009
Sarah Houlton |
New HIV vaccine hope A team of scientists in the US has discovered two new antibodies that could lead to an HIV vaccine. |
Pharmaceutical Executive
December 1, 2005
Alana Klein |
Thought Leader: A Q&A with Graham Allaway While researchers continue to hunt for new AIDS drugs, Graham Allaway, chief operating officer of Panacos Pharmaceuticals, is focusing on developing a treatment for patients failing therapy due to resistance. |
Salon.com
August 21, 2001
David Horowitz |
The AIDS obstructionists As the AIDS epidemic spins out of control, special interest groups are preventing one of the only things that can work -- mandatory testing... |
The Motley Fool
September 24, 2009
Brian Orelli |
Drugmakers' HIV Treatments Live On Companies that make HIV drugs could lose billions of dollars in revenue if an effective vaccine is developed. All drug-company investors need to keep an eye on up-and-coming drugs from competitors that could take market share. |
Salon.com
May 18, 2000
Sabin Russell |
The dream and the coming disaster AIDS threatens to ravage the hopes of South Africa's young democracy. Don't expect leaders to get excited because a few companies cut the cost of HIV drugs. |
Pharmaceutical Executive
February 1, 2009
Joanna Breitstein |
Vaccines for All The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most. |
Chemistry World
February 9, 2007
Victoria Gill |
Africa's First Large-Scale HIV Vaccine Trial The first large-scale clinical trial of an HIV vaccine will involve around 3000 participants in five selected sites in South Africa. It will compare the effectiveness of the vaccine at reducing HIV infection compared to a placebo. |
The Motley Fool
December 14, 2006
Stephen Albainy-Jenei |
Merck Gets Punk'd by Thailand Thailand issues a compulsory license to manufacture a generic version of Merck's patented AIDS drug. This is an act of humanitarian aid, but it is also an avenue for price and profit erosion worldwide. |
Salon.com
June 9, 2000
Arthur Allen |
Heart of darkness A team of Los Alamos researchers traces AIDS back to the 1930s, blowing a hole in the most recent theory about its origin. |
Pharmaceutical Executive
July 3, 2007
Jill Wechsler |
Washington Report: Vaccines for Everyone New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access, and to bring necessary medications to third-world countries. |
Salon.com
December 1, 2000
Fiona Morgan |
It's World AIDS Day ... again Americans with insurance now improve with new drugs, but the disease is on a rampage across the rest of the world... |
ifeminists
July 28, 2004
Wendy McElroy |
AIDS Efforts Undermined by U.N. Politics Politics lies at the root of the U.N.'s constant bashing of American policies. In the shifting vista of AIDS politics, where even the figures are blurring, the U.S. is correct and prudent to withhold its support. |
BusinessWeek
January 29, 2007
Kerry Capell |
GlaxoSmithKline: Getting AIDS Drugs To More Sick People GlaxoSmithKline sells 90% of its vaccines, in volume terms, at not-for-profit prices to customers in the developing world. |
Popular Mechanics
December 1, 2006
Ben Harder |
Fighting HIV by Building a New Killer In the fight to find a cure for AIDS, researchers have invented a viral double agent on a mission to seek out where HIV hides. |
The Motley Fool
July 13, 2006
Carrie Crockett |
2 Bills Are Better Than 1 It remains to be seen exactly how closely Gates and Clinton will work together, but the current trend toward megaphilanthropy among corporate, political, and entertainment giants can only bring a surge of desperately needed help to the global community. |
IDB America
September 2001
Charo Quesada |
The cost of silence The executive director of UNAIDS urges Latin America and the Caribbean to break the silence surrounding AIDS if they wish to avert greater tragedy... |
Salon.com
July 17, 2000
Nina Teicholz |
When drugs take a holiday Could taking a break from protease inhibitors be the secret to treating AIDS? A new case of a 40-year-old man in Philadelphia shows it's possible. |
Salon.com
May 21, 2002
Peter Kurth |
Quack record Bestselling health and fitness guru Gary Null weighs in on AIDS. Almost all of what he says is useless, dangerous and just plain wrong... |
BusinessWeek
August 2, 2004
Arnst & Einhorn |
Why Business Should Make AIDS Its Business Some multinational companies are taking baby steps to control the AIDS in their workforce, but more needs to be done. |
HBS Working Knowledge
February 28, 2005
Cynthia Churchwell |
Funding R&D for Neglected Diseases Research on vaccines for diseases that primarily affect low-income countries remains minimal---the risks are too high for developers. The book Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases suggests a solution. |
Chemistry World
August 20, 2014
Maria Burke |
Doctors turn to experimental Ebola treatments The emergency use of an experimental medicine is highly unusual, but the WHO has declared the Ebola outbreak a public health emergency of international concern. |
Salon.com
February 4, 2000
Emily Bass |
A new urgency With his country at the epicenter of an AIDS epidemic, the special advisor to South Africa's health minister quietly makes his first trip to an important research conference. |
Salon.com
March 19, 2001
Ben Barber |
Fighting the plague The World Trade Organization steps into Africa's AIDS crisis, creating incentives for pharmaceutical companies to give some of their drugs away. |
Scientific American
July 2006
JR Minkel |
Dangling a Carrot for Vaccines Drug companies do not see much of a market in treating diseases of developing nations. Michael Kremer hopes to change that with a plan that taps the profit motive. |
Salon.com
May 1, 2001
Daryl Lindsey |
Amy and Goliath A first-year law student brought a giant pharmaceutical to its knees. But will her victory for South Africa's AIDS sufferers deprive the world of new medicines? |
Salon.com
May 8, 2001
Daryl Lindsey |
The "Joe Camel" ads of AIDS? The FDA says ads for drugs to suppress HIV are making false promises, and could be contributing to an epidemic of unsafe sex... |
Salon.com
June 1, 2001
Daryl Lindsey |
The AIDS-drug warrior Outspoken AIDS-drug activist Jamie Love says pharmaceutical companies must be forced to yield their patents to save hundreds of thousands of lives. Is he a visionary -- or a dangerous radical? |
Finance & Development
March 1, 2002
Robert Hecht |
Making AIDS Part of the Global Development Agenda AIDS is not just a health issue but a development problem that must be addressed at the global level. As countries increasingly recognize the need to incorporate strategies for tackling AIDS in their national policy frameworks, they are looking at new national poverty reduction plans... |
Salon.com
June 26, 2000
Arthur Allen |
Vaginal detergent Can a germ-killing suppository like Biofem's Inner Confidence protect women against HIV? |
Salon.com
July 13, 2000
Megan Williams |
African mothers: Save us, too AIDS activists say providing drugs to prevent HIV transmission to babies but not treating their mothers is unconscionable. |
| AskMen.com |
Adventures In Circumcision The most powerful force against AIDS in Africa may be circumcision, a procedure that's easily done in the developed world. |
BusinessWeek
June 28, 2004
Amy Barrett |
Jonas Salk: He Put An End To Polio In the '50s, Dr. Jonas Salk moved with lightning speed to develop and test a vaccine for polio. |
Mother Jones
August 2000
Jacob Levenson |
A Time for Healing African Americans now account for the majority of new AIDS cases. But a crusading Harlem pastor believes the black church can slow the epidemic's spread. |
IDB America
February 2002
Charo Quesada |
Leadership, consensus, and technology With broad support from society, Brazil is improving the quality of life of HIV carriers... |
Chemistry World
July 8, 2010
Sarah Houlton |
Antibodies spark HIV vaccine hopes These cross-reactive broadly neutralising antibodies bound to and neutralised more than 90 per cent of the HIV strains they were tested against. |
The Motley Fool
December 30, 2008
Brian Orelli |
A Shot in the Arm for Novartis' Pipeline The company picks up the rights to a vaccine that fights a virus. |
